This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Breakpoint Therapeutics Gmbh. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: The Innovative Contributions of Jonathan Hollick
Introduction
Jonathan Hollick is a notable inventor based in Hamburg, Germany. He has made significant strides in the field of cancer treatment through his innovative research and development. With a total of two patents to his name, Hollick is recognized for his contributions to medical science.
Latest Patents
Hollick's latest patents focus on a DNA polymerase theta inhibitor for the treatment of cancer. The present invention relates to a compound that inhibits Polθ, which is implicated in various diseases and conditions, particularly cancer. This novel therapeutic compound is designed to be useful for the treatment and prevention of such diseases. Additionally, the invention includes pharmaceutical compositions comprising this compound, processes for synthesizing it, and its applications in treating conditions associated with Polθ activity.
Career Highlights
Jonathan Hollick is currently associated with Breakpoint Therapeutics GmbH, where he continues to advance his research in cancer therapies. His work is characterized by a commitment to developing innovative solutions that address critical health challenges.
Collaborations
Hollick collaborates with esteemed colleagues, including Andrea Guerrero Corella and Stuart Robert Flanagan, who contribute to his research endeavors.
Conclusion
Jonathan Hollick's work exemplifies the spirit of innovation in the medical field, particularly in cancer treatment. His patents and ongoing research hold promise for future therapeutic advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile